Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura   Chamblin Beth   McMahon Lori   Nair Ayyappan   Thomas Mary   Wakefield John   Koentgen Frank   Ramabhadran Ram  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite

Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

By Smith Jonathan   Chakrabarti Enakshi   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 145-147

Humana Press, Inc

Access to resources Recommend Favorite

Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer’s disease drug candidate screening

By Chang Lei   Bakhos Lara   Wang Zhiqiang   Venton Duane   Klein William  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 305-313

Humana Press, Inc

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite